New Efficacy Data Reinforces NEXTSTELLIS® Benefits Across Patient Populations
Results presented at the 2021 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting
News provided by
Share this article
Share this article
GREENVILLE, N.C., April 30, 2021 /PRNewswire/ Mayne Pharma announced today results from two studies showing treatment with NEXTSTELLIS® (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) demonstrated contraceptive efficacy and excellent cycle control across subgroups, including age, body mass index (BMI)[1] and prior contraceptive use. NEXTSTELLIS is the first contraceptive pill containing E4, a new naturally occurring estrogen with a unique mechanism of action that offers potential advantages over other estrogens. The findings were presented at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting, held virtually in the U.S. from April 30 – May 2.
New Data Show NEXTSTELLIS® Has Selective Impact On Endocrine Markers Compared With Common Combined Oral Contraceptives
Results presented at the annual meeting of the International Society for the Study of Women s Sexual Health
News provided by
Share this article
Share this article
RALEIGH, N.C., March 6, 2021 /PRNewswire/ Mayne Pharma announced today new data showing treatment with NEXTSTELLIS®,
1 a novel, investigational combined oral contraceptive (COC) containing drospirenone (DRSP) and estetrol (E4), resulted in limited changes in endocrine markers, including lower increases in hormone binding globulins, compared with COCs based on ethinyl-estradiol (EE), the synthetic estrogen used in all but one of the marketed COCs. The data was presented at the annual meeting of the International Society for the Study of Women s Sexual Health (ISSWSH), held virtually in the U.S. from March 5-7.
New Data Show NEXTSTELLIS® Has Selective Impact On Endocrine Markers Compared With Common Combined Oral Contraceptives prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.